Drug Profile
Ethinylestradiol/norethindrone acetate vaginal - Pfizer
Alternative Names: CI 1001Latest Information Update: 12 Feb 2015
Price :
$50
*
At a glance
- Originator Pfizer
- Class Alkylated estrogenic steroids; Hormonal contraceptives; Norpregnatrienes; Norpregnenes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pregnancy
Most Recent Events
- 12 Feb 2015 Discontinued - Phase-III for Pregnancy (Prevention) in USA (Vaginal) prior to February 2015
- 21 Jun 2000 Warner-Lambert has merged with Pfizer
- 31 Mar 2000 Phase-III clinical trials for Contraception/Pregnancy (Prevention) in USA (Vaginal)